479 related articles for article (PubMed ID: 30846171)
21. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
22. A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Song DE; Sung TY; Yoon JH; Hong SJ; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2017 Apr; 176(4):371-378. PubMed ID: 28089996
[TBL] [Abstract][Full Text] [Related]
23. The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma.
Hu JQ; Wen D; Ma B; Zhang TT; Liao T; Shi X; Wang YL; Zhu YX; Wang Y; Wei WJ; Ji QH
Cancer Med; 2020 Feb; 9(3):1017-1024. PubMed ID: 31854077
[TBL] [Abstract][Full Text] [Related]
24. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.
Kim Y; Roh JL; Song D; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2020 Oct; 122(5):906-913. PubMed ID: 32588461
[TBL] [Abstract][Full Text] [Related]
25. The optimal surgical approach for papillary thyroid carcinoma with pathological n1 metastases: An analysis from the SEER database.
Ji T; Chen J; Mou J; Ni X; Guo Y; Zhang J; Wang S; Wang W; Zhang X; Tai J
Laryngoscope; 2020 Jan; 130(1):269-273. PubMed ID: 30953386
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
27. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
28. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
[TBL] [Abstract][Full Text] [Related]
29. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
[No Abstract] [Full Text] [Related]
30. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
[TBL] [Abstract][Full Text] [Related]
31. Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.
Lee SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg; 2019 May; 269(5):966-971. PubMed ID: 29462007
[TBL] [Abstract][Full Text] [Related]
32. Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma.
Ahn D; Lee GJ; Sohn JH
Br J Surg; 2020 May; 107(6):687-694. PubMed ID: 32026467
[TBL] [Abstract][Full Text] [Related]
33. Individualizing Surgery in Papillary Thyroid Carcinoma Based on a Detailed Sonographic Assessment of Extrathyroidal Extension.
Kuo EJ; Thi WJ; Zheng F; Zanocco KA; Livhits MJ; Yeh MW
Thyroid; 2017 Dec; 27(12):1544-1549. PubMed ID: 29113553
[TBL] [Abstract][Full Text] [Related]
34. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
[TBL] [Abstract][Full Text] [Related]
35. Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?
Fujiwara T; Yoshizawa A; Mizuta M; Tamaki H
Auris Nasus Larynx; 2021 Feb; 48(1):148-153. PubMed ID: 32718811
[TBL] [Abstract][Full Text] [Related]
36. Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy.
Matsuura D; Yuan A; Harris V; Shaha AR; Tuttle RM; Patel SG; Shah JP; Ganly I
Thyroid; 2022 Jan; 32(1):28-36. PubMed ID: 34861772
[No Abstract] [Full Text] [Related]
37. Extent of surgery affects survival for papillary thyroid cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS; Sturgeon C
Ann Surg; 2007 Sep; 246(3):375-81; discussion 381-4. PubMed ID: 17717441
[TBL] [Abstract][Full Text] [Related]
38. The Identification of Intraoperative Risk Factors Can Reduce, but Not Exclude, the Need for Completion Thyroidectomy in Low-Risk Papillary Thyroid Cancer Patients.
Craig SJ; Bysice AM; Nakoneshny SC; Pasieka JL; Chandarana SP
Thyroid; 2020 Feb; 30(2):222-228. PubMed ID: 31813323
[No Abstract] [Full Text] [Related]
39. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
Zhao H; Gong Y
Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
[TBL] [Abstract][Full Text] [Related]
40. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
DiMarco AN; Wong MS; Jayasekara J; Cole-Clark D; Aniss A; Glover AR; Delbridge LW; Sywak MS; Sidhu SB
BJS Open; 2019 Jun; 3(3):299-304. PubMed ID: 31183445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
